Calma, Baby Girl -.

HRN: 23-76-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/22/2023
10/29/2023
IV
40mg
Q24H
Thickly MSAF
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: